X-ray structures of Sap 1 and Sap5:: Structural comparison of the secreted aspartic proteinases from Candida albicans

被引:50
作者
Borelli, Claudia [1 ]
Ruge, Elisabeth [1 ]
Lee, Jung Hoon [2 ]
Schaller, Martin [3 ]
Vogelsang, Alexandra [2 ]
Monod, Michel [4 ]
Korting, Hans Christian [1 ]
Huber, Robert [2 ]
Maskos, Klaus [2 ]
机构
[1] Univ Munich, Dept Dermatol & Allergy, D-80337 Munich, Germany
[2] Max Planck Inst Biochem, D-82152 Martinsried, Germany
[3] Univ Tubingen, Dept Dermatol, D-72076 Tubingen, Germany
[4] CHU Vaudois, Serv Dermatol DHURDV, Lab Mycol, CH-1011 Lausanne, Switzerland
关键词
candida albicans; inhibitor design; pepstatin A; secreted aspartic proteinase (Sap); X-ray crystal structure;
D O I
10.1002/prot.22021
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Proteolytic activity is an important virulence factor for Candida albicans (C albicans). It is attributed to the family of the secreted aspartic proteinases (Saps) from C. albicans with a minimum of 10 members. Saps show controlled expression and regulation for the individual stages of the infection process. Distinct isoenzymes can be responsible for adherence and tissue damage of local infections, while others cause systemic diseases. Earlier, only the structures of Sap2 and Sap3 were known. In our research, we have now succeeded in solving the X-ray crystal structures of the apoenzyme of Sap1 and Sap5 in complex with pepstatin A at 2.05 and 2.5 angstrom resolution, respectively. With the structure of Sap1, we have completed the set of structures of isoenzyme subgroup Sap1-3. Of subgroup Sap4-6, the structure of the enzyme Sap5 is the first structure that has been described tip to now. This facilitates comparison of structural details as well as inhibitor binding modes among the different subgroup members. Structural analysis reveals a highly conserved overall secondary structure of Sap1-3 and Sap5. However, Sap5 clearly differs from Sap 1-3 by its electrostatic overall charge as well as through structural conformation of its entrance to the active site cleft. Design of inhibitors specific for Sap5 should concentrate on the S4 and S3 pockets, which significantly differ from Sapl-3 in size and electrostatic charge. Both Sap1 and Sap5 seem to play a major part in superficial Candida infections. Determination of the isoenzynies' structures can contribute to the development Of new Sap-specific inhibitors for the treatment of superficial infections with a structurebased drug design program.
引用
收藏
页码:1308 / 1319
页数:12
相关论文
共 56 条
[1]  
AbadZapatero C, 1996, PROTEIN SCI, V5, P640
[2]   Glycosylphosphatidylinositol-anchored proteases of Candida albicans target proteins necessary for both cellular processes and host-pathogen interactions [J].
Albrecht, A ;
Felk, A ;
Pichova, I ;
Naglik, JR ;
Schaller, M ;
de Groot, P ;
MacCallum, D ;
Odds, FC ;
Schäfer, W ;
Klis, F ;
Monod, M ;
Hube, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (02) :688-694
[3]   Analysis of crystal structures of aspartic proteinases: On the role of amino acid residues adjacent to the catalytic site of pepsin-like enzymes [J].
Andreeva, NS ;
Rumsh, LD .
PROTEIN SCIENCE, 2001, 10 (12) :2439-2450
[4]   Biosensor-based screening and characterization of HIV-1 inhibitor interactions with Sap 1, Sap 2, and Sap 3 from Candida albicans [J].
Backman, D ;
Monod, M ;
Danielson, UH .
JOURNAL OF BIOMOLECULAR SCREENING, 2006, 11 (02) :165-175
[5]   The secreted aspartic proteinases as a new target in the therapy of candidiasis [J].
Bein, M ;
Schaller, M ;
Korting, HC .
CURRENT DRUG TARGETS, 2002, 3 (05) :351-357
[6]   The crystal structure of the secreted aspartic proteinase 3 from Candida albicans and its complex with pepstatin A [J].
Borelli, Claudia ;
Ruge, Elisabeth ;
Schaller, Martin ;
Monod, Michel ;
Korting, Hans Christian ;
Huber, Robert ;
Maskos, Klaus .
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2007, 68 (03) :738-748
[7]   The expression of the secreted aspartyl proteinases Sap4 to Sap6 from Candida albicans in murine macrophages [J].
Borg-von Zepelin, M ;
Beggah, S ;
Boggian, K ;
Sanglard, D ;
Monod, M .
MOLECULAR MICROBIOLOGY, 1998, 28 (03) :543-554
[8]   Crystallography & NMR system:: A new software suite for macromolecular structure determination [J].
Brunger, AT ;
Adams, PD ;
Clore, GM ;
DeLano, WL ;
Gros, P ;
Grosse-Kunstleve, RW ;
Jiang, JS ;
Kuszewski, J ;
Nilges, M ;
Pannu, NS ;
Read, RJ ;
Rice, LM ;
Simonson, T ;
Warren, GL .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1998, 54 :905-921
[9]   APPLICATION OF A FLUOROGENIC SUBSTRATE IN THE ASSAY OF PROTEOLYTIC ACTIVITY AND IN THE DISCOVERY OF A POTENT INHIBITOR OF CANDIDA-ALBICANS ASPARTIC PROTEINASE [J].
CAPOBIANCO, JO ;
LERNER, CG ;
GOLDMAN, RC .
ANALYTICAL BIOCHEMISTRY, 1992, 204 (01) :96-102
[10]   Antiretroviral therapy with protease inhibitors has an early, immune reconstitution-independent beneficial effect on Candida virulence and oral candidiasis in human immunodeficiency virus-infected subjects [J].
Cassone, A ;
Tacconelli, E ;
De Bernardis, F ;
Tumbarello, M ;
Torosantucci, A ;
Chiani, P ;
Cauda, R .
JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (02) :188-195